Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy

WEDNESDAY, Aug. 12, 2026-- Deramiocel, a heart-derived cellular therapy consisting of human allogeneic cardiosphere-derived cells, can safely slow progression of advanced Duchenne muscular dystrophy (DMD), according to a study published online...